- Home
- KYMR vs CBU Comparison
KYMR vs CBU Comparison
Compare KYMR & CBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- CBU
- Stock Information
- Founded
- KYMR 2015
- CBU 1866
- Country
- KYMR United States
- CBU United States
- Employees
- KYMR N/A
- CBU N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- CBU Major Banks
- Sector
- KYMR Health Care
- CBU Finance
- Exchange
- KYMR Nasdaq
- CBU Nasdaq
- Market Cap
- KYMR 3.0B
- CBU 3.7B
- IPO Year
- KYMR 2020
- CBU N/A
- Fundamental
- Price
- KYMR $42.30
- CBU $65.15
- Analyst Decision
- KYMR Buy
- CBU Buy
- Analyst Count
- KYMR 16
- CBU 4
- Target Price
- KYMR $54.00
- CBU $65.25
- AVG Volume (30 Days)
- KYMR 456.9K
- CBU 169.2K
- Earning Date
- KYMR 10-31-2024
- CBU 01-21-2025
- Dividend Yield
- KYMR N/A
- CBU 2.72%
- EPS Growth
- KYMR N/A
- CBU 12.06
- EPS
- KYMR N/A
- CBU 3.13
- Revenue
- KYMR $87,563,000.00
- CBU $706,337,000.00
- Revenue This Year
- KYMR N/A
- CBU N/A
- Revenue Next Year
- KYMR $33.16
- CBU $8.72
- P/E Ratio
- KYMR N/A
- CBU $20.82
- Revenue Growth
- KYMR 86.92
- CBU 10.20
- 52 Week Low
- KYMR $22.35
- CBU $41.50
- 52 Week High
- KYMR $53.27
- CBU $73.39
- Technical
- Relative Strength Index (RSI)
- KYMR 41.34
- CBU 42.26
- Support Level
- KYMR $40.95
- CBU $65.85
- Resistance Level
- KYMR $44.17
- CBU $67.57
- Average True Range (ATR)
- KYMR 2.32
- CBU 1.68
- MACD
- KYMR -0.33
- CBU -0.64
- Stochastic Oscillator
- KYMR 16.07
- CBU 1.57
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
About CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company that is focused on four main business lines banking, benefits administration, insurance services and wealth management. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. Key revenue is generated from banking business.